Last update July 22, 2022
Very Low Risk
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
メフェナム酸 is Mefenamic Acid in Japanese.Is written in other languages:
メフェナム酸 belongs to this group or family:
Main tradenames from several countries containing メフェナム酸 in its composition:
|Protein Binding||> 90||%|
|Tmax||2 - 4||hours|
|T½||2 - 4||hours|
|Theoretical Dose||0.026 (0.005 - 0.1)||mg/Kg/d|
|Relative Dose||0.2 (0.04 - 0.8)||%|
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
It is a low-potency nonsteroidal anti-inflammatory drug (NSAID). It is used for mild to moderate pain (headache, dental, postoperative, postpartum, dysmenorrhea, menorrhagia, osteoarthritis, and rheumatoid arthritis). Oral administration three to four times a day.
Excretion into breast milk is non-significant without side-effects reported in breastfed infants from treated mothers. (Buchanan 1968)
It was not found, or, only in very low levels neither in the plasma nor the urine of those infants. (Buchanan 1968)
Several medical societies and expert authors consider the use of this medication to be safe or very probably safe during breastfeeding (Briggs 2015, Nice 2004, Goldsmith 1989). The American Academy of Pediatrics (2012) rates it as a maternal medication that is usually compatible with breastfeeding. (AAP 2001)
Until more published data is known about this drug in relation to breastfeeding, known safer alternatives are preferable, especially during the neonatal period and in the event of prematurity. (LactMed, Sachs 2013)